Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
it amazes me this publication has been ignored..too busy talking among yourselves i suppose..
http://www.mdpi.com/2076-3271/6/1/9/htm
its not a stretch to read into these new hires as AA filing for hpv constructs..not to mention partnerships with constructs tailored to enhance the partners treatment..lots of posters concentrate on a few trees in this adxs forest ..but the overall future is vert bright. i bought more yesterday..there is such little trading i was the only one who bought warrants..caused the warrant price to go up 27%..manipulators must have been too busy with the share price to bring down warrants.
pretty amazing.. the price did not fall yesterday ..but went up..wow.
no capitulation..not even close..if it did not occur yesterday not likely anytime soon..the sun is coming up..later today..
expect another down week this week..talking never changed the weather or adxs share price..8-10 million short shares are firmly in charge..have been in charge and will remain in charge as long as the funding is there..Management has failed to protect share hold value let alone create it..at least as far as the share price is concern..some strategy to loosen the short grip is necessary..isn't that what the BOD should be doing..strategy.
how is it possible to predict the value of a stock whose significant owners are bent on driving the company they own out of business. thats the underlying operandus here and has been for many months..as long as there is plenty of money and short shares available i don't see how anything other than a sustained market demand can help..and what will cause that other than sustained revenue stream..
8 to 10 million short shares, lack of much buyer interest precipitated by orchestrated selling managed by an engineered trading bot are three other reasons..but that aside, the disruptive nature to SOC and the cost/benefit ratio the treatment offers has made it a primary target of current soc investors for all types of cancer..and it is currently in no ones interest to protect the share price..with market weakness we should see a gradual float down to 2.50..s/p range..whats to stop it?
here's hoping the share price crashes..think we will see it soon..just before AA or ema submission..or partnership news..considering number of short shares we have been bought and sold many times over the last several years. plenty of interest and money available to bring price lower.
is this 3.00 price share harvesting, negotiation strategy..soc protection..its cheap manipulating it down here..wise ones are accumulating..losers are selling..amgen closed 500million dollar deal on pre clinical neo..now as universal booster vaccine and big pharma already participating with prostate construct and several trials with hpv..plus limited commercialization of her2 vaccine for dogs..and good news every week..how long will we be 3.00..?ignoring the good news can last just so long..
lets increase the size of BOD so we can all have a seat..
that would be refreshing and healthy to see so many unhappy investors who post here sell their holding..i'll bet the pps would not move unless it was pre programmed into the bot..and the little uprising to try and influence employee policy is both ridiculous and naive..as are most interpretations of this share authorization move as being dilution..surely the entity backing this little ihub adxs drama deserves more for their money..get real.
seems to me from reading this board that adxs is plagued by self serving and incompetent management that is destroying share holder value through massive dilution plans..with all the other well run companies to invest in..adxs seems like a very poor choice for new investors..and current shareholders should plan an exit strategy..must be more good news coming soon.
short selling to increase supply of available shares for trading within a constant share price environment is an obvious effort to keep price down..also indicates share demand is up at these prices requiring more shares to maintain current s/p..seems simple to me..8 million + short shares added to volume represents a 20% temp trading dilution..take those away and the demand exceeds supply and price goes up..not complicated.
a .30 stock with an efficacious treatment for solid tumor cancer..i can buy and wait..no problem
so what news has pre market at 2.75 a share..potential buying by board posters? LOL..imminent good news?..or just SOS..because they can..adxs has a universal partner vaccine..and very efficacious on its own..good reason for SOC providers to spend deep to destroy or at least delay it.
news does not matter..nothing does but share supply/demand.
adxs could easily see 10 billion eval..and about 50 million shares..means ~ 200.00 a share..isn't that why you invested its why i did..and i believe adxs future is very bright..so do our shorts that's why they are funding this share price..and why it would be futile to release prs..so we all wait for a while..how long..who knows..if it gets to be too much no one is holding anybody hostage..besides the stock would be behaving the same with or without
so what if true..so what if not..makes no difference..milestones are all that matter..they are gearing up for production..
this new arrangement is for industrial production and engineering of LM constructs...its amazing really..
here's a challenge for our amazingly skillful shorts..take it to a new 52 week low by Friday cob..
thanks for the link..makes you remember what adxs is about..its easy to forget these days..price action over the months past definitely has made us a wait and see stock..shorts have done a good job..even managed to ignore the commercialization approval granted petx..groundbreaking really..first new cancer treatment in decades..and just ignored..looking forward to some in your face prs..it is necessary..
do not forget adxs dual which homes in on hpv subtypes and derived from the analysis of the GOG study..dual phase 3 with big pharma partner schedule for this year..wow been reading the same bull bear sentiment for months and months now..would think this would have played out long time ago..
makes since adxs would have applied for AA with fda as they have the gog study which was submitted for EMA
it appears demand for stock has increased significantly during the past two weeks or so..evidenced by trading above the average with a price that remains higher or within a given range..if this continues then the s/p will take care of itself as it becomes more expensive to keep the price down..covering should reduce the number of shares available for trading..but that has not happened yet..new investor demand combined with short covering will provide an upward pressure on the s/p. good news will exacerbate the current volume trend.
its hard to know..but i don't believe there are many shares available at these prices..and we will likely see an increase in short interest required to run the price down to here and keep it there..but short covering may not be the primary objective here..billions of revenue are up for grabs over the next few years with immuno replacing radiation and chemo in the treatment of cancer..personal ambitions for a few retail investors are hardly relevant..bull or bear..this year or next.. listeria vaccine is now on the market..offered by petx..others to follow.only 40 million shares..no debt..many opportunities for fund raising if nec..including licensing revenue past and future..our partners are happy..trials moving forward..interest in cancer vaccines will grow..the intensity of short attacks on stock is just evidence of the progress adxs LM tech is making..
different year sos here..
True ..been buying between 80 and 90 cents..amazing price.
.maybe more next week..but warrants price is guarded..
how many months have i been reading about incompetent management..slow results and adxs' shorts running the place..yet we continue to make progress..pay our bills and progress the science towards approval..recent petx approval..upcoming ema submission..several big pharma partners..are shorts covering..or simply shorting more to run the price down with increased volume..how to tell..impossible..speculation, innuendo, and irrelevant conclusions are all we have here..nothing justifies the take down..but trying to find more shares to cover..while there seems nothing to celebrate about the share price..i believe recent increase in volume trading may portend increase in demand for shares as adxs success begins to surface..and the slowest week on wall street the venue for large increase in trading volume..adxs is a big threat to soc in every indicator it is pursuing..revolutions are not easy..losers become winners and vice versa..we will see..we have the money to withstand..and shareholders seem patient save some of the anonymous voices here.
nice post chemist..2018 will be pivotal no doubt..i've noticed the volume has been increasing as of late with the share price pretty much in the same range..meaning demand for shares may finally be increasing..if it continues..shorts will find their games getting more expensive..expect short interest is up from the 8 million after the last couple weeks. They are a tenacious bunch with remedy through long term sustained increasing demand for shares...
"Amgen did not say how much of its $38.9 billion in cash and other holdings it plans to move back to the United States. To encourage U.S. companies to bring home the more than $2.6 trillion now held overseas, the law sets a one-time tax repatriation rate of 15.5 percent for cash and cash-equivalents and 8 percent for illiquid assets."
this should help with any adxs funding issues.. our partners are big recipients..if we have a future in cancer treatments we will see it in 2018..cash, opportunity, science fda re-org should be the end or the lift off for us.
not so sure whats happened the last week..know that petx approval was buried like it never happened even though that was the first LM product to get commercial approval..but from the annual report it is clear adxs does not plan to enter the retail drug arena, or manufacturing, except neo..which is good..they are continuing to focus on lead candidates at this time that have capability of earlier revenue generation..and are playing the short term game..( 1 or 2 years out) not the longer term retail plan that doc was doing..did i get led into believing there would be revenue announcement..yes..but my bad..not the company..still believe petx approval will make us more attractive as we have a commercial LM product..first one..a milestone completely ignored except for 2 million shares exchanged then folowed by sell off because no revenue announcement..
volume of course is key..2 million shares yesterday a good start but was met with shorts likely selling into it which reduced any uptick/breakout pressure..that's not sustainable if volume is unrelenting..if it is not..then a small spike then back to the doldrums of bouncing on the 3's..our shorts are strong and must be met with stronger bull response..unrelenting..and there seem to be plenty of shares available short term to meet any temporary spike up with enough selling to thwart the momentum
first LM construct to commercialize..so what does that do for the value of HER2 construct? maybe we know soon enough..
the personal investment needs for those of us who are here is not a factor in rolling out this tech..The LM platform has come a long ways since its early days..become more effective and shown to alter the tumor environment..programmable listeria is the key to multiple treatments in future world..and with dna repair algorithms..disease prevention and life extension without aging seems possible one day..the whole notion of adxs tech is new..that means traditional forms of treatment are replaced with prevention and targeted less destructive treatments..try and see beyond daily share price changes and remember what brought you here in the first place and have some faith in your initial thinking and beliefs despite the financial assault on the stock for the last three years..
amazing to me we live in a world where a strain of bacteria can be used to provide genetic cancer targets then alter the cancer cells internal environment once attached..i expect the vector could be used to deliver specific dna repair algorithms..one day..
how would a revenue stream forecast effect the stock..all total something less than 50 million shares..so 1 billion eval..40.00 a share.etc. consider axal, dual, anal, head and neck, prostate, licensing, amgen, selene..world wide distribution..s/p is a joke..shorts have set this up for the mother of all runs..aside from smart retail nibbling on the edge..3.15 is a joke..future annual earning * 10..?
Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA efforts to support more efficient development of targeted therapies.
December 15, 2017
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm589248.htm
this is LM platform..
never understood why so many longs are so negative on their investment here..and have been negative for so long..warrants were up 37%..and despite the overwhelming negative sentiment i believe we will see a solid plan going forward financed by partnerships and milestone payments..adxs is going big..warrants have been a great buy enabling an investor to control appreciation on 3-4xs the number of shares vs a single share purchase..time will tell..not the sentiment posted here. i have been happily buying sub dollar warrants..annd if that opp continues will continue to buy this gift..8 million short shares may soon need to cover..
8 million short shares about 20% of the company is borrowed..the s/p is ridiculous and warrants less than snickers bar..foolish shorts..wasn't the shorts big argument financial viability to support rapid growth and doesn't this kill the idea of dilution as a worry..
"ADXS is a fast-growing firm, which supports having have zero-debt and financial freedom to continue to ramp up growth. Since there is also no concerns around ADXS’s liquidity needs, this may be its optimal capital structure for the time being." plus
"Are you a potential investor? ADXS’s high growth makes financial flexibility an attractive option. In addition, its high liquidity ensures the company will continue to operate smoothly should unfavourable circumstances arise."
we will soon see revenue and product announcements to follow..........8 million shorts should start looking for shares..rathe than just trying to surpress the s/p..
market is waiting for news that cancer vaccines can be commercialized..silence keeps the share price circa 3.00...selling is sparse..buying is limited..hfts respond to increase share demand..while it may allow interim increases its trajectory down resumes after share demand declines..no interest in protecting s/p by anyone..biggest interest..8 million short shares that cannot be bought..meanwhile lots of shares being bought over this extended, protracted silence. .cost of maintaining low s/p over time beginning to mount..short interest seems unaffected..longs are accumulating..warrants get protected..but at a 1.00...these prices represent three year lows..warrants even cheaper..warrants seem like a good bet with risk about a 1/3 of s/p..this goes big or goes home and with 40million share count and 8 million short shares..more likely to propel up with news..